Not applicableUnknownNCT03284255
What this trial is testing
Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study
Who this might be right for
Coronary Artery DiseaseAntineoplastic Agents
Shanghai Bio-heart Biological Technology Co., Ltd. 431